Research Areas
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Education
2007 - 2008
2007 - 2008Post Doctorate
Johannes Kepler Universitaet Linz, Engineering And Natural Sciences, Austria
2001 - 2002
2001 - 2002Post Doctorate
Université Louis-Pasteur: Strasbourg I, Inserm Unite 424, France
1997 - 2001
1997 - 2001Post Doctorate
University of Essex, Faculty Of Sciences And Health, School Of Biological Sciences, England
1994 - 1997
1994 - 1997Doctorate
University of Essex, Faculty Of Science And Health, School Of Biological Sciences, United Kingdom
Dissertations
2000
2000Doctorate
Gene Trap Screening For Genes Expressed Preferentially In Low Serum Conditions
University of Essex, Bilim ve Sağlık Fakültesi, Biyolojik Bilimler
Foreign Languages
C1 Advanced
C1 AdvancedFrench
C1 Advanced
C1 AdvancedEnglish
B1 Intermediate
B1 IntermediateSpanish
Certificates, Courses and Trainings
2020
2020European Joint Programme Rare Diseases-Online Workshop Implementing Biomedical Research Projects: The Complete Workflow from Concept, ELSI and Privacy Considerations to High-Quality Biobanking
Health&Medicine
European Joint Programme Rare Diseases
Academic Positions
2023 - Present
2023 - PresentProfessor
Istanbul University, Instıtute of Chıld Health, Rare Diseases
2021 - Present
2021 - PresentAssociate Professor
Istanbul University, Istanbul Medical Faculty, Basic Medical Sciences
2019 - Present
2019 - PresentAssociate Professor
Istanbul University, Instıtute of Chıld Health, Dahili Tıp Bilimleri Bölümü
2014 - 2017
2014 - 2017Professor
Muhimbili University of Health and Allied Sciences (MUHAS), Basic Sciences, Biochemistry
Managerial Experience
2022 - Present
2022 - PresentHead of Department
Istanbul University, Instıtute of Chıld Health, Nadir Hastalıklar
2014 - 2018
2014 - 2018Director of the Center
Muhimbili University of Health and Allied Sciences (MUHAS), Medical Faculty, Basic Medical Sciences/Biochemistry & Genetics
Non Academic Experience
2014 - 2018
2014 - 2018Ziyaretçi Profesör
Muhimbili University of Health and Allied Sciences, Ziyaretçi Profesör
2014 - 2018
2014 - 2018Genetik Laboratuvarı Kurucusu, Sorumlu Yönetici
Muhimbili University of Health and Allied Sciences, Genetik Laboratuvarı Kurucusu, Sorumlu Yönetici
2006 - 2014
2006 - 2014Araştırma Görevlisi-Uzman
Johannes Kepler -Linz Üniversitesi, Araştırma Görevlisi-Uzman
2000 - 2002
2000 - 2002Araştırma Görevlisi-Uzman
Charles Sadron Enstitüsü, Araştırma Görevlisi-Uzman
1997 - 2001
1997 - 2001Araştırma Görevlisi-Uzman
Essex Üniversitesi, Araştırma Görevlisi-Uzman
Supervised Theses
in Progress
in ProgressDoctorate
Genetic Screening for Hereditary Breast Cancer in Females and their First-Degree Relatives in Tanzania
Atalar F.
L.Rweyemamu(Student)
in Progress
in ProgressPostgraduate
Tıp öğrencilerinin ve doktorların nadir hastalıklara ilişkin farkındalığı
Atalar F. (Advisor)
İ.Karagöz(Student)
2020
2020Doctorate
Investigation of 9p21.3 region in African Tanzanian Coronary Artery Disease Patients
Atalar F.
G.Akan(Student)
2018
2018Postgraduate
Investigation of clinical implication of soluble HLA-G and immunogenetic influence of HLA-G 3142G/C polymorphism in cervical and breast cancer development among patients attending ORCI in Tanzania
Atalar F.
I.Adolf(Student)
2007
2007Postgraduate
Regulation of PI3K/Akt Signalling Pathway in AML: A Novel Tumor-Supressor PHLPP
Atalar F. (Co-Advisor), Karabay Korkmaz A.
A.Tuğçe(Student)
Representation and Promotion Activities
Muhimbili İnsan Genetik Laboratuvarı Kurulması
Institutional Representation, Muhimbili Tıp Fakültesi, Tanzania, Dar-Es-Salaam, 2015 - 2018
Articles
2026
20261. Glutaric acidemia type 1 in a non-newborn-screened cohort: clinical, biochemical, and molecular features and neurologic outcomes
SELAMİOĞLU A., İdrisoğlu M., Kılıç Ş., Güneş D., KARACA M., Balcı M. C., et al.
Italian Journal of Pediatrics , vol.52, no.1, 2026 (SCI-Expanded, Scopus)
2026
20262. Isotretinoin suppresses key pro-inflammatory cytokines at transcriptional and systemic levels in acne vulgaris
Akan G., Bostanci A., Tuncel G., Maden S., Mullaaziz D., Atalar F.
ARCHIVES OF DERMATOLOGICAL RESEARCH , vol.318, no.1, 2026 (SCI-Expanded, Scopus)
2026
20263. Expanding the Clinical Spectrum of Mitochondrial Phosphate Carrier Deficiency: A Case Report With Literature Review
Selamioglu A., ALTUN M., Bliven K., Ünverengil G., Güneş D., KARACA M., et al.
American Journal of Medical Genetics, Part A , vol.200, no.2, pp.438-445, 2026 (SCI-Expanded, Scopus)
2026
20264. Association ofADIPOQ Gene Variants and Circulating Adiponectin Levels with Coronary Artery Disease Risk
Akan G., GÖRMEZ S., ATALAR F.
CYPRUS JOURNAL OF MEDICAL SCIENCES
, vol.11, no.1, pp.40-47, 2026 (ESCI, TRDizin)
2025
20255. Alamandine enhanced spatial memory in rats by reducing neuroinflammation and altering BDNF levels in the hippocampus and prefrontal cortex
KILIÇ A., İPEK B. E., Tatonyan S., Kilic K., Demirci H., ATALAR F., et al.
Scientific Reports , vol.15, no.1, 2025 (SCI-Expanded)
2025
20256. Enhancing Rare Disease Awareness and Education Among Medical Professionals and Students in Türkiye
Karagöz Ö., Tırtır B., Güneş D., Özgen Ö., Özçetin M., Gökçay G., et al.
Journal of Evaluation in Clinical Practice , vol.31, no.5, 2025 (SCI-Expanded, Scopus)
2025
20257. Thyroid Hormone Dynamics and DIO2 Variants in Schizophrenia: Exploring Genetic Links to Neuroendocrine Imbalance
Akan G., Adolf I. C., Colak A., Acar S., Oncu F., Yesilbursa D., et al.
Journal of Cellular and Molecular Medicine
, vol.29, no.13, 2025 (SCI-Expanded, Scopus)
2025
20258. Development and validation of a carnitine cycle and transport disorders (CCD) panel: an ONT-compatible multi-gene diagnostic kit for newborn and selective screening.
Akan G., Balcı M. C., Tuncel G., Karaca M., Kazan H. H., Özketen A. Ç., et al.
Orphanet journal of rare diseases , vol.20, no.1, pp.250, 2025 (SCI-Expanded, Scopus)
2025
20259. Benchmarking Nanopore Sequencing for CLN2 (TPP1) Mutation Detection: Integrating Rapid Genomics and Orthogonal Validation for Precision Diagnostics
Teker B., Akan G., Kazan H. H., ÖZGEN ÇOBAN Ö., Tatonyan S., BALCI M. C., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.26, no.11, 2025 (SCI-Expanded, Scopus)
2025
202510. An Oxford Nanopore Technologies-Based Sequencing Assay for Molecular Diagnosis of Phenylketonuria and Variant Frequencies in a Turkish Cohort.
Tuncel G., Balcı M. C., Akan G., Kazan H. H., Özgen Ö., Özketen A. Ç., et al.
International journal of genomics , vol.2025, no.1, pp.5552662, 2025 (SCI-Expanded, Scopus)
2025
202511. Challenges in the clinical management of rare diseases and center-based multidisciplinary approach to creating solutions
Gunes D., Karaca M., Durmus A., Ak B., Aktay Ayaz N., Altınel Z. U., et al.
EUROPEAN JOURNAL OF PEDIATRICS
, vol.184, no.5, 2025 (SCI-Expanded, Scopus)
2025
202512. Alpha-mangostin and nab-paclitaxel in breast cancer cell models: improved antitumor efficacy through combination therapy.
Özgen Ö., Çetin İ., Atalar F., Topçul M. R.
Cellular and molecular biology (Noisy-le-Grand, France)
, vol.71, no.1, pp.52-59, 2025 (SCI-Expanded, Scopus)
2024
202413. Oxidative damage and mitochondrial dysfunction in cystathionine beta-synthase deficiency
Balci M. C., GEDİKBAŞI A., Dogan S. A., Kahraman S., Tatoryan S., Neijmann S. T., et al.
Scientific Reports , vol.14, no.1, 2024 (SCI-Expanded, Scopus)
2024
202414. Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.
Kazan H. H., Karaca M., Akan G., Özgen Ö., Tuncel G., Özketen A. Ç., et al.
Gene , vol.928, pp.148782, 2024 (SCI-Expanded, Scopus)
2024
202415. The efficacy of high pressure liquid chromatography (HPLC) in detecting congenital glycosylation disorders (CDG)
Ozgen O., Güdek Klllç F., Gedikbaşl A., Balcl M. C., Karaca M., Durmuş A., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, 2024 (SCI-Expanded)
2024
202416. Severity of coronary artery disease is associated with diminished circANRIL expression: A possible blood based transcriptional biomarker in East Africa.
Akan G., Nyawawa E., Nyangasa B., Turkcan M. K., Mbugi E., Janabi M., et al.
Journal of cellular and molecular medicine , vol.28, no.3, 2024 (SCI-Expanded, Scopus)
2023
202317. Breast cancer in East Africa: Prevalence and spectrum of germline SNV/indel and CNVs in BRCA1 and BRCA2 genes among breast cancer patients in Tanzania
Rweyemamu L. P., Gultaslar B. K., Akan G., Dharsee N., Namkinga L. A., Lyantagaye S. L., et al.
CANCER MEDICINE
, vol.12, no.3, pp.3395-3409, 2023 (SCI-Expanded, Scopus)
2023
202318. The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis
Adolf I. C., Rweyemamu L. P., Akan G., Mselle T. F., Dharsee N., Namkinga L. A., et al.
CANCER MEDICINE
, vol.12, no.1, pp.472-487, 2023 (SCI-Expanded, Scopus)
2022
202219. HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine
Adolf I. C., Almars A., Dharsee N., Mselle T., Akan G., Nguma I. J., et al.
GENES & DISEASES
, vol.9, no.5, pp.1220-1233, 2022 (SCI-Expanded, Scopus)
2022
202220. Association of XRCC1-Arg399Gln and XPG-Asp1104His polymorphisms with reproductive risk factors and increased risk of breast cancer in Tanzanian patients
Adolf I. C., Akan G., Rweyemamu L. P., Atalar F.
EUROPEAN JOURNAL OF HUMAN GENETICS
, vol.30, no.SUPPL 1, pp.377, 2022 (SCI-Expanded, Scopus)
2021
202121. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women
Rweyemamu L. P., Akan G., Adolf I. C., Magorosa E. P., Mosha I. J., Dharsee N., et al.
BMC WOMENS HEALTH
, vol.21, no.1, 2021 (SCI-Expanded, SSCI, Scopus)
2021
202122. Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
Görmez S., Kırışoğlu Demir C. E., Ekicibasi M. E., Degirmencioglu A., Paudel A., Akan G., et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
, vol.49, no.4, pp.286-293, 2021 (ESCI, Scopus, TRDizin)
2021
202123. Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-1.
Gormez S., Gumusel H. K., Ekicibasi E., Degirmencioglu A., Paudel A., Akan G., et al.
Bratislavske lekarske listy
, vol.122, no.8, pp.582-589, 2021 (SCI-Expanded)
2019
201924. Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.
GORMEZ S., ERDIM R., AKAN G., CAYNAK B., DURAN C., GUNAY D., et al.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology , vol.46, pp.107192, 2019 (SCI-Expanded, Scopus)
2019
201925. Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.
Adolf I., Akan G., Mselle T., Dharsee N., Namkınga L., Atalar F.
Asian Pacific journal of cancer prevention : APJCP
, vol.20, pp.3465-3472, 2019 (SCI-Expanded, Scopus)
2019
201926. Intronic variants in the long non-coding RNA CDKN2B-AS1 are strongly associated with the risk of coronary artery dise ase in the Northern Tribes of Tanzania.
Atalar F., Akan G., Janabi M.
Tanzania Journal of Health Research , vol.21, no.1, pp.1-14, 2019 (Scopus)
2019
201927. Common SNP-based haplotype analysis of the 9p21.3 gene locus as predictor coronary artery disease in Tanzanian population
Akan G., Kisenge P., Sanga T. S., Mbugi E., Adolf I., Turkcan M. K., et al.
CELLULAR AND MOLECULAR BIOLOGY , vol.65, no.6, pp.33-43, 2019 (SCI-Expanded, Scopus)
2016
201628. Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma
Oksuz E., Atalar F., Tanirverdi G., Bilir A., Shahzadi A., Yazici Z.
JOURNAL OF NEURO-ONCOLOGY
, vol.126, no.2, pp.271-278, 2016 (SCI-Expanded, Scopus)
2015
201529. herg1b Expression as a Potential Specific Marker in Pediatric Acute Myeloid Leukemia Patients with HERG 897K/K Genotype
Erdem M., Tekiner T. A., Fejzullahu A., Akan G., Anak S., Saribeyoglu E. T., et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.32, no.3, pp.182-192, 2015 (SCI-Expanded, Scopus)
2015
201530. PAI-1 and TNF-alpha profiles of adipose tissue in obese cardiovascular disease patients
Gazioglu S. B., Akan G., Atalar F., Erten G.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
, vol.8, no.12, pp.15919-15925, 2015 (SCI-Expanded, Scopus)
2013
201331. Mediastinal adipose tissue expresses a pathogenic profile of 11 β-hydroxysteroid dehydrogenase Type 1, glucocorticoid receptor, and CD68 in patients with coronary artery disease
Atalar F., Gormez S., Caynak B., Akan G., Tanriverdi G., Bilgic-Gazioglu S., et al.
CARDIOVASCULAR PATHOLOGY , no.3, pp.183-188, 2013 (SCI-Expanded, Scopus)
2013
201332. Identification of a Novel BRCA2 and CHEK2 A-C-G-C Haplotype in Turkish Patients Affected with Breast Cancer
Haytural H., Yalcinkaya N., Akan G., ARIKAN S., Ozkok E., Cakmakoglu B., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, vol.14, no.5, pp.3229-3235, 2013 (SCI-Expanded, Scopus)
2013
201333. Growth Hormone/Insulin-Like Growth Factor-1 Axis as Related to Body Mass Index in Patients with Idiopathic Short Stature
Cengiz P., Bas F., Atalar F., Ucar A., Darendeliler F., Akan G., et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY , vol.5, no.1, pp.13-19, 2013 (SCI-Expanded, Scopus)
2013
201334. OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis
TUGCU V., SIMSEK A., Tarhan T., Atalar F., BITKIN A., TASCI A. I., et al.
RENAL FAILURE
, vol.35, no.6, pp.825-829, 2013 (SCI-Expanded, Scopus)
2012
201235. The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease
Atalar F., Gormez S., Caynak B., Akan G., Tanriverdi G., Bilgic-Gazioglu S., et al.
CARDIOVASCULAR DIABETOLOGY , 2012 (SCI-Expanded, Scopus)
2012
201236. THE ASSOCIATION BETWEEN SERUM OSTEOPONTIN LEVELS AND OPN ALA 250 POLYMORPHISM IN UROLITHIASIS
Tarhan T., Tugcu V., Atalar F., Bitkin A., Sonmezay E., ALTUĞ T., et al.
JOURNAL OF ENDOUROLOGY , vol.26, 2012 (SCI-Expanded, Scopus)
2012
201237. No Effect of the IGF-1 Gene rs35767 and rs17032362 Polymorphisms in the Etiology of Idiopathic Short Stature
Tekcan D., Bas F., Atalar F., Aydin B. K., Akan G., Tarhan T., et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.120, no.7, pp.395-400, 2012 (SCI-Expanded, Scopus)
2012
201238. 11 beta-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease
Atalar F., Vural B., Ciftci C., Demirkan A., Akan G., Susleyici-Duman B., et al.
GENETICS AND MOLECULAR RESEARCH
, vol.11, no.3, pp.3122-3132, 2012 (SCI-Expanded, Scopus)
2011
201139. Adipose Tissue Gene Expression of Adiponectin, Tumor Necrosis Factor-alpha and Leptin in Metabolic Syndrome Patients with Coronary Artery Disease
GORMEZ S., DEMIRKAN A., Atalar F., Caynak B., ERDIM R., SÖZER V., et al.
INTERNAL MEDICINE
, vol.50, no.8, pp.805-810, 2011 (SCI-Expanded, Scopus)
2010
201040. Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study
Atalar F., Acuner T. T., Çine N., Oncu F., Yesılbursa D., Ozbek U., et al.
BEHAVIORAL AND BRAIN FUNCTIONS , vol.6, 2010 (SCI-Expanded, Scopus)
2009
200941. A study on the prevalence of metabolic syndrome and the relation with polymorphism of a leptin receptor gene GIn223Arg in schizophrenia inpatients with and without treatment resistance
Oncu F., Atalar F., Acuner T. T., Turkcan S., Yesilbursa D., Uygur N.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , vol.19, 2009 (SCI-Expanded, TRDizin)
2009
200942. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.
Baş F., Kayserili H., Darendeliler F., Uyguner O., Günöz H., Yüksel A., et al.
Journal of clinical research in pediatric endocrinology
, vol.1, pp.116-28, 2009 (SCI-Expanded, Scopus)
2008
200843. Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome
Vural B., Atalar F., Ciftci C., Demirkan A., Susleyici-Duman B., Gunay D., et al.
CARDIOVASCULAR PATHOLOGY
, vol.17, no.6, pp.392-398, 2008 (SCI-Expanded, Scopus)
2008
200844. Localization of the ergtoxin-1 receptors on the voltage sensing domain of hERG K+ channel by AFM recognition imaging
CHTCHEGLOVA L. A., Atalar F., Ozbek U., WILDLING L., EBNER A., HINTERDORFER P.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY , vol.456, no.1, pp.247-254, 2008 (SCI-Expanded, Scopus)
2003
200345. Bioactive coatings based on a polyelectrolyte multilayer architecture functionalized by embedded proteins
JESSEL N., Atalar F., LAVALLE P., MUTTERER J., DECHER G., SCHAAF P., et al.
ADVANCED MATERIALS , vol.15, no.9, pp.692-695, 2003 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. Rapid and Accurate Phenylketonuria Diagnosis: Integrating ONT-Based Molecular Screening into Newborn Programs
Tuncel G., BALCI M. C., Akan G., Kazan H. H., Ozgen O., Ozketen A. C., et al.
58th Conference of the European-Society-of-Human-Genetics (ESHG), Milan, Italy, 24 - 27 May 2025, vol.33, pp.404, (Summary Text)
2025
20252. in silico pathogenicity analysis of CPT-1, CPT-2 and OCTN2 Variants in Carnitine Cycle and Transport Disorders reveals structural and functional impacts
Akan G., BALCI M. C., Tuncel G., KARACA M., Ozketen A. C., Kazan H. H., et al.
58th Conference of the European-Society-of-Human-Genetics (ESHG), Milan, Italy, 24 - 27 May 2025, vol.33, pp.400, (Summary Text)
2024
20243. Development and Clinical Validation of an Oxford Nanopore-Based Multigene Panel for the Diagnosis of Carnitine Cycle Defects
GÖKÇAY G. F., BALCI M. C., TUNCEL DEREBOYLU G., KARACA M., KAZAN H. H., Özketen Ç., et al.
X. International congress of Molecular Medicine 2024, 23 - 27 September 2024, (Full Text)
2024
20244. Evaluating Unmet Needs of Parents Caring for Children with Hereditary Metabolic Diseases: A call to action for Türkiye
ATALAR F., KARACA M., Özgen Ö., BALCI M. C., ÇOLAK Ü., GÜNEŞ D., et al.
SSIEM Annual Symposium 2024, 03 September 2024, (Full Text)
2024
20245. UNMET NEEDS OF CAREGIVERS FOR RARE DISEASES: A SYSTEMATIC ANALYSIS OF BIOTINIDASE DEFICIENCY, PHENYLKETONURIA, AND MUCOPOLYSACCHARIDOSES
ÖZGEN Ö., yeşil a., GÜNEŞ D., BALCI M. C., KARACA M., GÖKÇAY G. F., et al.
II. INTERNATIONAL CONGRESS ON ADVANCED RESEARCH AND APPLICATIONS, Azerbaijan, 19 September 2024, (Full Text)
2024
20246. Unmet Needs Of Caregivers For Rare Diseases: A Systematic Analysis Of Biotinidase Deficiency, Phenylketonuria, And Mucopolysaccharidoses. 2.
Atalar F.
Uluslararası İleri Araştırmalar Ve Uygulamalar Kongresi Sivas Cumhuriyet Üniversitesi , Sivas, Turkey, 19 September 2024, pp.114-115, (Full Text)
2024
20247. DETERMINATION OF COGNITIVE AND NEUROPSYCHIATRIC EFFECT OF PHENYLKETONURIA AT EARLY TREATED ADULT PATIENTS; MR SPECTROSCOPY AND PHENYLALANINE LEVELS: PRELIMINARY RESULTS
KARACA M., KURT E., Kizilates Evin G., SELAMİOĞLU A., Canlı M., BALCI M. C., et al.
SSIEM 2024 Annual Symposium, Porto, Portugal, 3 - 06 September 2024, (Summary Text)
2024
20248. Lysosomal Enzyme Activity Testing Process Quality Assurance During the Preanalytic- Analytic and Postanalytic Lab Phases
Gedikbaşı A., Kılıç Ş., Güneş D., Ak B., Çolak Aktaş Ü., Karaca M., et al.
24) SSIEM ANNUAL SUMPOSİUM, Porto, Portugal, 2 - 06 September 2024, pp.1, (Full Text)
2024
20249. Circulating cell-free mitochondrial DNA as a proinflammatory DAMP for inherited hemolytic anemia
Tekin Neijmann Ş., GEDİKBAŞI A., Doğan Ş. A., Tatonyan S., BALCI M. C., Bekmez B., et al.
48th FEBS CONGRESS, Milan, Italy, 29 June 2024, pp.484, (Summary Text)
2024
202410. Üre Döngüsü Bozukluğu Tanılı Çocukların Ebeveynlerinin Deneyimleri; Sosyodemografik Veriler Ve Karşılaşılan Zorluklar
Tırtır Yılmaz B., Balcı M. C., Karaca M., Atalar F., Gökçay G. F.
XVII. Uluslararası Katılımlı Metabolik Hastalıklar ve Beslenme Kongresi, Antalya, Turkey, 28 April - 02 May 2024, pp.289-290, (Summary Text)
2023
202311. Retrospective Analysis Of Carbohydrate-Deficient Transferrin For CDG Screening: A Single Center Study
Özgen Ö., Güdek Kılıç F., Gedikbaşi A., Balci M. C., Karaca M., Durmuş A., et al.
SSIEM Annual Symposium 2023, Tel-Aviv-Yafo, Israel, 29 August 2023, vol.46, pp.257, (Summary Text)
2023
202312. Mitochondrial dysfunction in a disorder of transsulphuration: Cystathionine β-synthase deficiency
Balcı M. C., Gedikbaşı A., Kahraman S., Tatonyan S., Tekin Neijmann Ş., Karaca M., et al.
SSIEM Annual Symposium 2023, Tel-Aviv-Yafo, Israel, 29 August 2023, vol.46, pp.148, (Summary Text)
2023
202313. Rapid, accurate and comprehensive diagnostic method for the detection of Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease using long-read third-generation sequencing technology
Teker B., Tatonyan S., Balcı M. C., Karaca M., Akan G., Özgen Ö., et al.
SSIEM Annual Symposium 2023, Tel-Aviv-Yafo, Israel, 29 August - 01 September 2023, vol.46, no.686, pp.361, (Summary Text)
2023
202314. Fluorometric Analysis and Validation of Tripeptidyl Peptidase-1 in Dry Blood Samples and Leukocytes in the Diagnosis of Neuronal Ceroid Lipofuxinosis 2
Teker B., Tatonyan S., Gedikbaşı A., Aydın A. F., Balcı M. C., Karaca M., et al.
VIII. Uluslararası Katılımlı Lizozomal Hastalıklar Kongresi, Bursa, Turkey, 3 - 07 May 2023, pp.64, (Summary Text)
2023
202315. Mitokondriyal Aminoasilt-RNA Sentetaz Eksikligi Olgularinda Serum FGF-21 Düzeylerinin Degerlendirilmesi
Tekin Neijmann Ş., Gedikbaşı A., Güneş D., Balcı M. C., Karaca M., Atalar F., et al.
TÜRK KLİNİK BİYOKİMYA DERNEĞİ XXIII. Ulusal Klinik Biyokimya Kongresi, Antalya, Turkey, 27 - 30 April 2023, pp.234, (Summary Text)
2022
202216. Prevalence and Spectrum of Germline SNV/indel and CNVs in BRCA1 and BRCA2 Genes among Breast Cancer Patients in Tanzania.
Rweyemamu L. P., Kurt Gültaşlar B., Akan G., Dharsee N., Namkinga L., Lyantagaye S., et al.
National Institute for Medical Research (NIMR) 31 st Annual Joint Scientific Conference, Dar-Es-Salaam, Tanzania, 6 - 08 May 2022, pp.324, (Summary Text)
2020
202017. Circulating lncRNA ANRIL: a potential biomarker in Tanzanian patients with coronary artery disease
Atalar F., Akan G., Janabi M.
European Human Genetics Virtual Conference, Berlin, Germany, 6 - 09 June 2020, pp.1124, (Summary Text)
2020
202018. DIO2 Thr92Ala Reduces Deiodinase 2 Activity and Serum T3 Levels in Patients with Schizophrenia.
Atalar F., Özgen Ö.
European Human Genetics Virtual Conference, 6 June - 09 September 2020, pp.1164, (Summary Text)
0
019. Konjenital Adrenal Hiperplazi Vakalarında LEP ve LEPR Gen Polimorfizmlerinin İnsülin Direnci ile İlişkilendirilmesi
BAŞ F., TARHAN T., ATALAR F., AKAN G., Demir G., DARENDELILER F., et al.
XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, pp.103, (Full Text)
2013
201320. Association study of the DIO2 gene as a susceptibility candidate for schizophrenia in the Turkish population; a case-control study
Colak A., Akan G., Oncu F., Yanbay H., Acar S., Yesilbursa D., et al.
21st European Congress of Psychiatry, Nice, France, 6 - 09 April 2013, pp.196, (Full Text)
2011
201121. İdiyopatik Boy Kısalığı Etiyopatogenezinde IGF-1 Gen Polimorfizmi Araştırılması
Tekcan D., Baş F., Atalar F., Akan G., Tarhan T., Darendeliler F.
33. Pediatri Günleri ve 12. Pediatri Hemşireliği Günleri, İstanbul, Turkey, 28 - 31 March 2011, pp.13, (Full Text)
2008
200822. Antipsikotik İlaç Kullanımına Bağlı QTc Aralığının Uzamasında HERG Kanallarının Genetık ve Fonksiyonel Yönlerinin Araştırılması
Atalar F., Oncu F., Chtceglova L., Turkcan S., Yesilbursa D., Hinterdorfer P., et al.
Katılımlı VIII. Ulusal Tıbbi Genetik Kongresi, Çanakkale, Turkey, 6 - 09 May 2008, pp.124, (Full Text)
2009
200923. A Significant Loss of Leucine Rich Repeat Domain in A Novel Candidate Tumour Suppressor Gene PHLPP in Cancer: Expression Studies
Tekiner T. A., Atalar F., Karabay A., Anak S., Özbek U.
European Society of Human Genetics Conference (ESHG) 2009, Vienna, Austria, 23 - 26 May 2009, pp.181, (Full Text)
2013
201324. Expression of obesity related genes and leptin serum levels are decreased in Turkish schizophrenıa patients, case-control study
Akan G., Özgen Ö., Colak A., Acar S., Oncu F., Yesilbursa D., et al.
21st European Congress of Psychiatry, Nice, France, 6 - 09 April 2013, no.1043, pp.172, (Full Text)
2010
201025. Çocukluk Çağı Obezitesinde IGF-1 Ve IGFBP-3 Genleri ile Lepin Gen Ekspresyonlarının Korelasyonunun Araştırılması
Atalar F., Baş F., Akan G., Tarhan T., Darendeliler F., Bundak R., et al.
XIV.Ulusal Pediatrik Endokrin ve Diyabet Kongresi, Muğla, Turkey, 4 - 10 October 2010, pp.122, (Full Text)
2009
200926. Leptin ve Leptin Reseptör Polimorfizmlerinin Çocukluk Çağı Obezitesi ile İlişkisi
Akan G., Atalar F., Baş F., Demir G., Tarhan T., Darendeliler F., et al.
XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, 17 - 21 November 2009, pp.160, (Full Text)
2013
201327. 11ß HSD-1 and PAI-1 Gene Expression Fructose Induced Metabolic Syndrome in Rats
Akan G., Inan O., Atalar F., Gormus U., Bilir A., Ozdilli K., et al.
12th FELASA SECAL Congress, Valencia, Spain, 19 - 22 June 2013, pp.109, (Full Text)
2009
200928. Crosstalk Between T-Cadherin and Wnt/B-Catenin Pathways in Cancer
Fejzullahu A., Tekiner T. A., Erdem M., Anak S., Özbek U., Atalar F.
European Society of Human Genetics Conference (ESHG) 2009, Vienna, Austria, 23 - 26 May 2009, pp.166, (Full Text)
2011
201129. The Association Between The Serum Osteopontin Levels and OPN Ala250 Polymorphism in Urolithiasis
Tarhan T., Atalar F., Tugcu V., Kural A. R., Bitkin A., Altuğ T.
European Human Genetics Conference (ESHG) 2011, Amsterdam, Netherlands, 28 - 31 May 2011, pp.178, (Full Text)
2009
200930. Çocukluk Çağı Obez ve Erişkin Metabolik Bozuklukları olan Hastalarda Leptin ve Leptin Reseptörü Polimorfizmlerinin Serum Leptin Seviyeleri ile Karşılaştırılması
Akan G., Atalar F., Baş F., Demir G., Tarhan T., Bundak R., et al.
Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, 8 - 10 October 2009, pp.112, (Full Text)
2008
200831. Increased Expression of Vascular Endothelial Factor Receptor-1 and The Loss of Estrogen Receptor beta in Pediatric Acute Myeloid Leukemia Patients
Atalar F., Tekiner T. A., Özbek U.
3rd ESF Conference on "Functional Genomics and Diseases (ESFFG), Innsbruck, Austria, 1 - 04 October 2008, pp.98, (Full Text)
2008
200832. Akut Miyeloid Lösemi’de Leptin Reseptör Geni İzoformlarının Ekspresyonu ve GLN223ARG Polimorfizmi
Atalar F., Özgen Ö., Özbek U.
VIII. Ulusal Tibbi Genetik Kongresi, Çanakkale, Turkey, 6 - 09 May 2008, pp.230, (Full Text)
2009
200933. The prevalence of metabolic syndrome in schizophrenia patients using single versus multiple antipsychotic drugs
Oncu F., Acuner T. T., Atalar F., Turkcan S., Yesilbursa D., Uygur N.
III. Ulusal Psikofarmakoloji Kongresi, Antalya, Turkey, 12 - 15 March 2009, pp.292-295, (Full Text)
0
034. The Crosstalk Between the Insulin-Like Growth Factor (IGF)-IGF Binding Proteins Axis and Leptin: Differential Impact of Childhood Obesity in IGF-1, IGFBP-3 and Leptin
ATALAR F., BAŞ F., AKAN G., TARHAN T., DARENDELILER F., BUNDAK R., et al.
European Society For Paediatric Endocrinology (ESPE), United Kingdom, pp.553, (Full Text)
2004
200435. Investigation of CYP21 gene mutations in congenital adrenal hyperplasia due to steroid 21 Hydroxilase Deficiency-old vs new diagnostic methods
Atalar F., Tükel T., Yüksel Apak M., Uyguner O., Kayserili H., Wollnik B.
VI. Ulusal Tibbi Genetik Kongresi, Antalya, Turkey, 21 - 24 April 2004, pp.53, (Full Text)
2011
201136. Gene Expression of HERG1, HERG2, HERG3 Isoforms in Peripheral Blood Mononuclear Cells of Schizophrenia Patients
Atalar F., Acuner T. T., Colak A., Akan G., Tekiner T. A., Oncu F., et al.
3rd. European Conference on Schizohrenia Research-Facts and Visions, Berlin, Germany, 29 September - 01 October 2011, pp.60, (Full Text)
0
037. “Leptin, Leptin Receptor, MC4R, PPAR Gamma and Osteopontin Gene Polymorphisms in Obese and Overweight Children”
ATALAR F., BAŞ F., AKAN G., TARHAN T., DARENDELILER F., AYDIN B. K., et al.
49th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), Czech Republic, pp.79, (Full Text)
0
038. Pediyatrik Akut Myeloid Lösemi Progresyonunda Yeni Bir Tümor Süppressör: PHLPP
TEKINER T. A., ATALAR F., Karabay A., Anak S., ÖZBEK U.
VIII. Ulusal Tibbi Genetik Kongresi, Çanakkale, Turkey, pp.124, (Full Text)
0
039. Intraserebellar Siçan C6 Glioblastomada COX1, COX2 ve COX3 Düzeyleri Üzerine Asetaminofen, Metamizol ve İndometasinin Etkileri
Öksüz E., Köse A., Kula M., ATALAR F., Celik H., YAZICI Z.
19. Ulusal Farmakoloji Kongresi, Eskişehir, Turkey, pp.220, (Full Text)
0
040. The Combinatory effect of KCNH2/hERG1 K897T and DIO2 Thr92Ala in the Susceptibility to Schizophrenia
Colak A., AKAN G., ONCU F., YESILBURSA D., TURKCAN S., ATALAR F.
Molecular Immunology & Immunogenetics Congress, (MIMIC2012), Antalya, Turkey, pp.135, (Full Text)
0
041. FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients
ATALAR F., SAYİTOĞLU M., HATIRNAZ O., ÖZBEK U.
30th World Congress of the International Society of Hematology, İstanbul, Turkey, pp.195, (Full Text)
0
042. Erken Obezite Tedavisi için Marker olan Pro12ALA Ppar? Ve VAL103ILE MC4R Polimorfizmlerinin Obez Çocuklardaki Sıklıklarının Araştırılması
Demir G., ATALAR F., BAŞ F., AKAN G., TARHAN T., DARENDELILER F., et al.
Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, pp.90, (Full Text)
0
043. İdiyopatik Boy Kısalığı Hastalarında IGF-1, IGFBP-3 Düzeyleri ve Gen Ekspresyonlarının İlişkisi
Cengiz P., ATALAR F., BAŞ F., BUNDAK R., DARENDELILER F., AKAN G., et al.
XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, pp.135, (Full Text)
0
044. “Expression of IGF-1, IGFBP-3, IGF-1R Genes in Idiopathic Short Stature
CENGIZ P., BAŞ F., BUNDAK R., ATALAR F., DARENDELILER F., AYDIN B. K., et al.
49th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), Czech Republic, pp.198, (Full Text)
0
045. Epicardial Adipose Tissue Fatty Acid Binding Protein 4 Expression Is Correlated With Extension Of Coronary Atherosclerosis In Patients With Metabolic Syndrome
GORMEZ S., DEMIRKAN A., ATALAR F., CAYNAK B., GUNAY D., AKPINAR B., et al.
78th Congress of the European-Atherosclerosis-Society, Germany, pp.207, (Full Text)
0
046. PHLPP Gene is Mutated in Pediatric Acute Myeloid Leukemia Patients and Might Act as A Tumor Suppressor Gene
TEKINER T. A., ATALAR F., Karabay A., Anak S., ÖZBEK U.
European Society of Human Genetics (ESHG), Spain, pp.214, (Full Text)
0
047. PPAR Gamma Gene Expression is Positively Correlated with Leptin and MC4R Expressions in Congenital Adrenal Hyperplasia
ATALAR F., BAŞ F., TARHAN T., AKAN G., DARENDELILER F., BUNDAK R., et al.
50th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), United Kingdom, pp.172, (Full Text)
0
048. Bir Eğitim ve Araştırma Hastanesinde Genetik Çalışmak, Biyobankalamanın Örnek-İşlem Sürecinin Tasarlanması ve Deneyimler
ATALAR F.
45.Ulusal Psikiyatri Kongresi, Antalya, Turkey, pp.179, (Full Text)
0
049. Wnt Sinyal İleti Yolunun T-Hücreli ve B-Hücreli Akut Lenfoblastik Lösemilerde Farklı Aktivasyonları
SAYİTOĞLU M., HATIRNAZ O., ATALAR F., ERBİLGİN Y., ÖZBEK U.
XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, pp.75, (Full Text)
0
050. The Critical Roles of STAMP2 and Proinflammatory Factor CD68 in Cardiometabolic Syndrome-Comparison of Genomic Findings with Clinical and Phenotypic Parameters”
ATALAR F., BILGIC-GAZIOGLU S., AKAN G., DEMIRKAN A., CAYNAK B., SAGBAS E., et al.
3rd ESF Functional Genomics Conference (ESFFG), Austria, pp.98, (Full Text)
0
051. Dysregulation Of Epicardial, Pericardial and Subcutaneous Adipokines in Obesity and Coronary Artery Disease
ATALAR F., GORMEZ S., CAYNAK B., GUNAY D., AKPINAR B., ÖZBEK U., et al.
European Human Genetics Conference (ESHG) 2011, Netherlands, pp.468, (Full Text)
0
052. Decreased WNT5A and FZ5 mRNA Levels contributes to Acute Lymphoblastic Leukemia (ALL)
SAYİTOĞLU M., HATIRNAZ O., ATALAR F., ÖZBEK U.
30th World Congress of the International Society of Hematology, İstanbul, Turkey, pp.196, (Full Text)
0
053. The prevalence of schizophrenia patients resistant and non-resistant to treatmentTedaviye Dirençli Olan ve Olmayan Şizofreni Hastalarında Metabolik Sendrom Sıklığı ve Leptin Reseptörü Geni Gln223arg Polimorfizmi ile İlişkisi
ONCU F., ATALAR F., ACUNER T. T., TURKCAN S., YESILBURSA D., Uygur N.
Bulletin of Clinical Psychopharmacology, Antalya, Turkey, pp.295, (Full Text)
0
054. Altered expression of Peroxysome Proliferator-Activated Receptor Gamma 2 and Serum Leptin Levels in Schizophrenia
AKAN G., Özgen Ö., ACUNER T. T., ONCU F., YESILBURSA D., TURKCAN S., et al.
European Human Genetics Conference (ESHG) 2011, Netherlands, pp.319, (Full Text)
0
055. Correlation of Leptin, Leptin Receptor Gene Polymorphism and Expression with Insulin Resistance in Congenital Adrenal Hyperplasia
BAŞ F., ATALAR F., DARENDELILER F., TARHAN T., AKAN G., AYDIN B. K., et al.
49th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), Czech Republic, pp.118, (Full Text)
0
056. Proinflamatuvar Bir Mediatör Olan Osteopontin ve Obezite
TARHAN T., ATALAR F., BAŞ F., AKAN G., Demir G., DARENDELILER F., et al.
Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, pp.113, (Full Text)
0
057. CYP21 Gene Mutations in Congenital Adrenal Hyperplasia due To 21-Hydroxylase Deficiency: Genotype-Phenotype Correlation in Turkish Children
ATALAR F., WOLLNIK B., DARENDELILER F., BAŞ F., GÜNÖZ H., KAYSERILI H., et al.
43rd Annual Meeting European Society for Paediatric Endocrinology, Switzerland, pp.109, (Full Text)
0
058. Konjenital Adrenal Hiperplazide Pro12Ala ve Val103 Polimorfizmlerinin İncelenmesi
TARHAN T., ATALAR F., BAŞ F., AKAN G., Demir G., DARENDELILER F., et al.
XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, pp.124, (Full Text)
0
059. Abberant expression of the obesity hormone leptin and its receptor in epicardial adipose tissue of obese and CAD patients
AKAN G., GORMEZ S., CAYNAK B., YAZICI Z., GUNAY D., DURAN C., et al.
Molecular Immunology & Immunogenetics Congress, (MIMIC2012), Antalya, Turkey, pp.136, (Full Text)
0
060. Comparison Of Adipose Tissue Gene Expression Of Adiponectin, Tumor Necrosis Factor-A and Leptin In Patients With And Without Metabolic Syndrome
GORMEZ S., DEMIRKAN A., CAYNAK B., ATALAR F., GUNAY D., AKPINAR B., et al.
78th Congress of the European-Atherosclerosis-Society, Germany, pp.20, (Full Text)
0
061. Leptin Ve Leptin Regülatörlerinin Çocukluk Çağı Obezitesindeki Rollerinin Araştırılması
AKAN G., TARHAN T., ATALAR F., BAŞ F., DARENDELILER F., BUNDAK R., et al.
XIV.Ulusal Pediatrik Endokrin ve Diyabet Kongresi, Muğla, Turkey, pp.207, (Full Text)
2019
201962. Implication of HLA-G+3142G>C Polymorphism and Soluble HLA-G in Mastectomized Breast Cancer Patients in Tanzania
Atalar F., Chatita A. I.
. 12th Conference of African Society of Human Genetics, Bamako, Mali, 19 September 2019 - 21 September 2020, pp.94, (Summary Text)
2018
201863. Evaluation of Association Between Common SNPs on 9p21.3 Region and Coronary Artery Disease in Tanzanian Population.
ATALAR F., Mbugi E., Akan G., Janabi M., Kisenge P., Sanga T.
5th World Congress on Epigenetics and Chromosome, İstanbul, Turkey, 15 November - 16 October 2018, pp.74-75, (Full Text)
2018
201864. Association of Chromosome 9p21.3 Region with Increased Risk of Coronary Artery Disease in Northern Tanzanian Patients.
Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.
34th Turkish Cardiology Congress with International Participation, Antalya, Turkey, 20 - 23 October 2018, pp.145-147, (Full Text)
2018
201865. Polymorphisms on Chromosome 9p21.3 Modify Susceptibility to Coronary Artery Disease and the Severity of Coronary Atherosclerosis in Tanzanian Population.
Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.
11th Conference of the AfSHG - African Society of Human Genetics., Darüsselam, Tanzania, 19 - 21 September 2018, pp.19-20, (Full Text)
2018
201866. Association of 9p21.3 With The Risk of Coronary Artery Disease in Tanzanian Patients
Akan G., Kisenge P., Mbugi E., Sanga T., Janabi M., ATALAR F.
The Sixth MUHAS Scientific Conference., Darüsselam, Tanzania, 2 - 03 July 2018, pp.114-116, (Full Text)
2018
201867. Polymorphisms in 9p21.3 locus are associated with coronary artery disease in Northern Tanzanian patients.
Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.
The Sixth MUHAS Scientific Conference., Darüsselam, Tanzania, 2 - 03 July 2018, pp.114-116, (Full Text)
2013
201368. TNF alfa ile indüklenen mRNA ve serum PAl lEkspresyonunu Metaborik Sendrom Üzerine Etkisi
BİLGİÇ GAZİOĞLU S., AKAN G., ATALAR F., GÖRMEZ S., KAYNAK B., SÖZER V., et al.
5. Detae Günleri, Turkey, 11 - 12 November 2013
2013
201369. TNF-α ILE İNDÜKLENEN PAI-1 mRNA EKSPRESYONU VE SERUM SEVIYESININ METABOLIK SENDROM ÜZERINE ETKISI
Bilgic-Gazioglu S., Akan G., Atalar F., Gormez S., Caynak B., Sozer V., et al.
22. Ulusal İmmünoloji Kongresi, İzmir, Turkey, 27 April 2013, pp.83, (Full Text)
2011
201170. IGF-1 and IGFBP-3 Levels and Distribution of IGF-1 Gene Polymorphisms in Idiopatic Short Stature
Tekcan D., Baş F., Atalar F., Akan G., Tarhan T., Darendeliler F.
European Society For Paediatric Endocrinology (ESPE), Glasgow, England, 25 - 28 September 2011, vol.76, pp.694, (Summary Text)
2009
200971. Obez Çocuklarda IGFBP-3 -202A/C Polimorfizmlerinin Serum IGFBP-3 ve IGF-1 Düzeyleri ile İlişkisi
Atalar F., Akan G., Baş F., Tarhan T., Demir G., Bundak R., et al.
Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, 8 - 10 October 2009, pp.116, (Full Text)
2009
200972. Alteration of HERG1 Isoform Expressions in Pediatric Acute Myeloid Leukemia and Solid Tumors: Expression Studies
Erdem M., Tekiner T. A., Fejzullahu A., Anak S., Özbek U., Atalar F.
European Society of Human Genetics Conference (ESHG) 2009, Vienna, Austria, 23 - 26 May 2009, pp.205, (Summary Text)
2007
200773. WNT pathway mutations in acute leukemia patients
Sayitoglu M., HATIMAZ O., ATALAR F., ERBILGIN Y., OZBEK U.
12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.55, (Summary Text)
2007
200774. Increased level of B-catenin mRNA and mutational alterations in APC gene are present in acute leukemia
ATALAR F., Sayitoglu M., HATIMAZ O., ERBILGIN Y., OZBEK U.
12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.62, (Summary Text)
2007
200775. Methylation status of the wnt antagonist DICKKOPF-1 gene in acute leukemias
ATALAR F., HATIRNAZ O., Sayitoglu M., ERBILGIN Y., OZBEK U.
12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.403, (Summary Text)
2006
200676. Upregulation of FZ5 results in abberant expression of beta-catenin and LEF/TCF complex in acute myeloid leukemia.
Atalar F., Hatirnaz O., Erbilgin Y., Ozbek U., Sayitoglu M., Ozbek U.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108
2006
200677. Different activation of WNT signaling pathway in B-cell and T-cell acute leukemias.
Sayitoglu M., HATIRNAZ O., Erbilgin Y., Atalar F., Ozbek U.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)
2006
200678. Kronik Lenfoblastik Lösemi Olgularında ZAP-70 Gen Ekspresyonunun RQ-PCR Yöntemi ile Tesbiti ve Prognostik Önemi
Coskunpınar E., Ure U., Baslar Z., Sayitoğlu M., Hatirnaz Ng Ö., Atalar F., et al.
XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 08 November 2006, pp.78, (Full Text)
2006
200679. Yüksek FZ5 Ekspresyonu Beta-Catenin/TCF-LEF Kompleksinin Atipik Ekspresyonunu Arttırarak Akut Myeloid Lösemi Gelişiminde Rol Oynar
Atalar F., Sayitoğlu M., Hatirnaz Ng Ö., Erbilgin Y., Özbek U.
XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 8 - 12 November 2006, pp.76, (Full Text)
2006
200680. 11 beta-HSD type 1 is responsible for low plasma hdl-cholesterol and abdominal obesity in metabolic syndrome patients
Atalar F., VURAL B., CIFTCI C., DEMIRKAN A., SUSLEYICI-DUMAN B., CAGATAY P., et al.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.203, (Summary Text)
2006
200681. Acylation stimulating protein and complement c3 mRNA expression in metabolic syndrome
DUMAN B. S., CIFTCI C., Atalar F., DEMIRKAN A., VURAL B., CAGATAY P., et al.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.205
2006
200682. The role of FABP4 gene expression in metabolic syndrome patients with previous myocardial infarction
VURAL B., Atalar F., DEMIRKAN A., CIFTCI C., DUMAN B. S., CAGATAY P., et al.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.204, (Summary Text)
2006
200683. Quantitative expression analysis of glucocorticoid receptor (GcR) gene in metabolic syndrome
DEMIRKAN A., Atalar F., VURAL B., DUMAN B. S., CIFTCI C., GUNAY G., et al.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.204, (Summary Text)
Books
2008
20081. General laboratory safety regulations
ATALAR F.
in: Genomik Uygulamalar, Özalpan A., Ünsal NP., Editor, T.C. İstanbul Kültür Üniversitesi Yayınları, İstanbul, pp.57-78, 2008
ATLAS Publication Analytics
Funded Projects
2026 - Present
2026 - PresentTürkiyeye Özgü OTC Mutasyonlarının Fonksiyonel İncelemesine Yönelik CRISPRTemelli Hepatik Hücre Modelinin Geliştirilmesi
Project Supported by Higher Education Institutions , BAP PhD
ATALAR F. (Executive), TIRTIR YILMAZ B.
2025 - 2026
2025 - 2026
Development and Clinical Validation of the Oxford Nanopore Platform-Specific Gene Panel for the Molecular Diagnosis of Treatable Lysosomal Storage Diseases
TUBITAK Project , 1000 - Üniversitelerin Araştırma ve Geliştirme Potansiyelinin Arttırılmasına Yönelik Destek Programı
(Project Abstract)
BALCI M. C. (Executive), GÖKÇAY G. F., ATALAR F.
2025 - Present
2025 - PresentLizozomal Depo Hastalıklarının Moleküler Tanısına Yönelik Oxford Nanopore Platformuna Özgü Gen Panelinin Geliştirilmesi ve Klinik Validasyonu
Project Supported by Higher Education Institutions , BAP Research Project
BALCI M. C. (Executive), GÖKÇAY G. F., ATALAR F., GEDİKBAŞI A., KARACA M., GÜNEŞ D., et al.
2025 - Present
2025 - Present
Notch Sinyal Yolağı İnhibisyonu ile Birlikte EGFR İnhibitörü Cetuximab Kullanımının Triple Negatif Meme Kanseri Hücreleri Üzerindeki Antikanser Etki Mekanizmalarının Araştırılması
Project Supported by Higher Education Institutions , BAP Research Project
ÇETİN İ. (Executive), GÜL Ş., ÇEP N., PULAT E., ÖZBAŞ S., ÖZGEN Ö., et al.
2024 - 2026
2024 - 2026Nadir Bir Lizozomal Depo Hastalığı olan Gaucher Hastalığının İmmünolojik ve Genetik Açıdan Değerlendirilmesi
Project Supported by Higher Education Institutions , BAP MSc
AKDENİZ N. (Executive), ATALAR F., TATONYAN S.
2024 - 2026
2024 - 2026Kalıtsal Metabolizma Hastalıklarında Metabolomik ve Lipidomik Profilleme ile Laboratuvarda Geliştirilen Testler
Project Supported by Higher Education Institutions , BAP Research Project
GEDİKBAŞI A. (Executive), DENİZ N. G., ÇOLAK AKTAŞ Ü., BALCI M. C., KILIÇ Ş., KARACA M., et al.
2024 - 2026
2024 - 2026
Evaluation of The Use of Targeted Antiproliferative Agents with Albumin-Bound Paclitaxel in Different Breast Cancer Cell Lines with Cellular Molecular and Bioinformatic Approaches
Project Supported by Higher Education Institutions , BAP Other
Topçul M. R. (Executive), Atalar F., Çetin İ., Tavşanlı N., Erözden A. A., Özgen Ö., et al.
2023 - 2024
2023 - 2024Depresyon Modeli Oluşturulan Sıçanlarda Alamandinin Kognitif Fonksiyonlara Ve Nöroinflamasyona Etkisi
TUBITAK Project , 1002 - Quick Support Program
Atalar F.
2023 - 2025
2023 - 2025ARDIŞIK KÜTLE SPEKTROMETRİSİ İLE GENİŞLETİLMİŞ YENİDOĞAN TARAMASINDA İKİNCİ BASAMAK MOLEKÜLER AYIRICI TANI İÇİN ÜÇÜNCÜ YENİ NESİL DİZİLEME TEKNOLOJİSİ KULLANILARAK KİT GELİŞTİRME
Project Supported by Higher Education Institutions , BAP Research Project
(Project Abstract)
GÖKÇAY G. F. (Executive), DURMUŞ A., PAZHOUHESH R., SÖYLEMEZ S., TEKER B., ATALAR F., et al.
2022 - 2025
2022 - 2025Hemoglobinopatilerde Okside Hemoglobin ve Mitokondriyal Hasar İlişkili Moleküler Paternler DAMPs ve NAD ile Antioksidanların İnvitro Potansiyel Terapötik Etkileri
Project Supported by Higher Education Institutions , BAP Research Project
KARAKAŞ Z. (Executive), ÖZBEÖZ O., TANYILDIZ H. G., GÖKÇAY G. F., ÖZHAN G., GEDİKBAŞI A., et al.
2020 - 2021
2020 - 2021
COVID-19 için predispozan faktör olarak hipertansiyon ve kardiyovasküler hastalıkların rolü: Diğer etkenlere bağlı viral pnömonilerle karşılaştırma
Ministry of Health
Pamukçu B., Görmez S., Atalar F.
2020 - 2021
2020 - 2021
D-Dimer düzeyi normal COVID-19 hastalarında düşük moleküler ağırlıklı heparin tedavisinin hastane içi sonlanımlara ve prognostik laboratuvar parametreleri üzerine etkisini incelemek
Project Supported by Other Official Institutions
Pamukçu B., Görmez S., Atalar F.
2020 - 2024
2020 - 2024
Breast cancer genes mutation analysis in the Hadzabe Ethnic group of Tanzania
Project Supported by Public Organizations in Other Countries
Atalar F.
2019 - 2022
2019 - 2022Tanzanya'da kalıtsal meme kanseri olan kadın hastalar ve birinci derece akrabalarının genetik taraması
Project Supported by Public Organizations in Other Countries
Atalar F. (Executive)
2013 - 2017
2013 - 20177q36.1 Genom Bölgesindeki HERG1 (KCNH2, Kv11.1)?genin,n şizofreni hastaları ve kontrollerde RNA Dizilemesi ve Biyoinformatik Analizi
Project Supported by Higher Education Institutions , BAP Other
ATALAR F. (Executive)
2013 - 2013
2013 - 20137q36.1 Genom Bölgesindeki HERG1 (KCNH2, Kv11.1)?geninin şizofreni hastaları ve kontrollerde RNA Dizilemesi ve Biyoinformatik Analizi
Project Supported by Higher Education Institutions , BAP Other
ATALAR F. (Executive)
2011 - 2012
2011 - 2012Şizofren hastalarının periferal kan hücrelerinde HERG1, HERG2 ve HERG3 izoformlarının ekspresyonu
Project Supported by Higher Education Institutions , BAP Other
ATALAR F. (Executive)
2010 - 2013
2010 - 201321 Hidroksilaz Eksikliğine bağlı konjenital adrenal hiperplazi vakalarında mutasyon aranması
Project Supported by Higher Education Institutions , BAP Research Project
ATALAR F. (Executive)
2009 - 2011
2009 - 2011Çocukluk Çağı Akut Myeloid Lösemi'de Insülin benzeri büyüme faktörleri (IGF-1 ve IGF-2), Insülin benzeri büyüme faktörleri reseptörü (IGFIR) ve IGF bağlayan proteinlere bağlı proteinler (IGFBP-rP1) ile apoptoz ilişkisi
Project Supported by Higher Education Institutions , BAP Other
ATALAR F. (Executive)
2006 - 2007
2006 - 2007Akut Myeloid Lösemi'de IGF Sisteminin Komponentlerini Oluşturan Genlerin IGF-1 ve 2 (Insulin-Like Growth Factor 1 ve 2) İle Reseptörlerinin Ekspresyonu: Apoptoz İle İlişkileri,
Project Supported by Other Official Institutions
ATALAR F. (Executive)
2004 - 2007
2004 - 2007"MedGeNet; EURO-MEDITERRANEAN NETWORK FOR GENETİC SERVİCES Network
EU Framework Program Project
ATALAR F.
Activities in Scientific Journals
2023 - Present
2023 - PresentFRONTIERS IN GENETICS
Assistant Editor/Section Editor
Memberships and Roles in Scientific Organizations
2023 - Present
2023 - PresentInborn error of metabolism genetics
Member
Peer Reviews in Scientific Publications
November 2025
November 2025FRONTIERS IN PEDIATRICS
Journal Indexed in SCI-E
September 2025
September 2025SCIENTIFIC REPORTS
Journal Indexed in SCI-E
August 2025
August 2025PLOS ONE
Journal Indexed in SCI-E
July 2025
July 2025ORPHANET JOURNAL OF RARE DISEASES
Journal Indexed in SCI-E
September 2022
September 2022JOURNAL OF KING SAUD UNIVERSITY - SCIENCE
SCI Journal
May 2022
May 2022Sabiad
National Scientific Refreed Journal
Mobility Activity
2007 - Present
2007 - PresentErasmus Programme
Scientific Research
Johannes Kepler Universitaet Linz, Austria
2026 - 2026
2026 - 2026Erasmus Programme
Staff Mobility
University of Dodoma, Tanzania
2014 - 2018
2014 - 2018Bilateral Colloboration Agreement
Staff Mobility
Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania
Congress and Symposium Activities
29 July 2026 - 31 July 2026
29 July 2026 - 31 July 20263rd UDOM Scientific Conference on Health (USCHe)
Invited Speaker
Dodoma-Tanzania
28 February 2023 - 28 February 2023
28 February 2023 - 28 February 20235. Nadir Hastalıklar Eğitim Toplantısı
Session Moderator
İstanbul-Turkey
02 February 2023 - 02 February 2023
02 February 2023 - 02 February 2023EURORDIS Black Pearl awards Ceremony, online
Audience
Paris-France
01 June 2022 - 01 June 2022
01 June 2022 - 01 June 2022Symposium Frontiers in Human exposome Research
Audience
Graz-Austria
28 May 2022 - 01 June 2022
28 May 2022 - 01 June 2022XVI. Uluslararası Katılımlı Metabolizma Hastalıkları ve Beslenme Kongresi
Attendee
Hatay-Turkey
18 May 2022 - 20 May 2022
18 May 2022 - 20 May 2022Nanopore- London Calling 2022
Attendee
London-England
17 April 2022 - 20 April 2022
17 April 2022 - 20 April 202244. Pediatri günleri ve 23. Pediatri Hemşireliği Günleri Kongresi
Moderator
İstanbul-Turkey
01 April 2022 - 01 April 2022
01 April 2022 - 01 April 202236. Marmara Metabolizma Grubu Toplantısı
Working Group
İstanbul-Turkey
04 March 2022 - 04 March 2022
04 March 2022 - 04 March 202235. Marmara Metabolizma Grubu Toplantısı
Working Group
İstanbul-Turkey
28 February 2022 - 28 February 2022
28 February 2022 - 28 February 20222022 Global Rare Disease Day Event, “Rare Diseases: a Global priority for Equity”
Attendee
London-England
28 February 2022 - 28 February 2022
28 February 2022 - 28 February 20224. Nadir Hastalıklar Eğitim Toplantısı, online
Attendee
İstanbul-Turkey
08 February 2022 - 08 February 2022
08 February 2022 - 08 February 2022EURORDIS Black Pearl awards Ceremony, online
Audience
Paris-France
Invited Talks
May 2023
May 2023INTERNATIONAL MULTIDISCIPLINARY ONLINE RARE DISEASES SYMPOSIUM
Conference
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ İZMİR TIP FAKÜLTESİ BİLİMSEL TOPLANTILARI – 32-Turkey
Jury Memberships
January-2021
January 2021